# Clinical and echocardiographic outcomes of combined CABG and MV repair

## TL;DR

This study shows that combining CABG with mitral valve repair improves heart function and reduces regurgitation in patients with multiple health issues.

## Contribution

The study provides evidence supporting CABG with MV repair as a viable treatment for patients with ischemic mitral regurgitation.

## Key findings

- 94.7% of patients improved to NYHA class II at discharge.
- 97.1% of patients had residual mitral regurgitation eliminated.
- 12-month outcomes were significantly improved despite high comorbidity.

## Abstract

A mixed-method observational study evaluated patients undergoing Coronary Artery Bypass Grafting (CABG) with mitral valve (MV) repair
for moderate to severe mitral regurgitation (MR). Most patients aged between 61-70 years (46.3%) and with 60% being male, 73% with Type
2 diabetes and 83.33% with triple-vessel coronary artery disease (CAD) (83.8%) and 15% with left main CAD. At discharge, 94.7% improved
to NYHA class II and residual MR was eliminated in 97.1% patients. This study demonstrates significantly improved 12-month outcomes,
with elimination of residual MR, supporting CABG with concomitant MV repair as a viable option for IMR patients despite high
comorbidity.